The
global Opioid Withdrawal Treatments Market Share will rise to USD 3.16 billion by the end of
the year 2032. The market valuation will grow at the CAGR rate of 10.1% over
the upcoming period. The global opioid withdrawal treatment market is
mainly driven by the growing opioid epidemic in North America and Europe and
the increasing awareness about various treatments that can be taken to reduce
opioid withdrawal symptoms. The high alertness in the U.S. and Europe with
regard to the overuse of prescribed opioid drugs is likely to remain a major
driver for the opioid withdrawal treatment market over the forecast period. The
growing healthcare industry and the growing prescription of opioid drugs in
these regions is likely to remain a key driver for the opioid withdrawal
treatment market over the forecast period.
Opioids
are usually prescribed for pain management and have become a widely popular
class of medications due to the absence of synthetic classes of drugs to
perform the same task. Usually, the healthcare industry uses a natural compound
as a platform for further variations and comes up with synthetic drug
formulations. However, the industry has been unable to do that with regard to
opioid drugs, as mimicking the analgesic effects of natural opioids has proved
too difficult. This has driven prescription figures for opioids and is likely
to remain a major driver for the opioid withdrawal treatment market over the
forecast period.
Competitive
Analysis:
Leading Opioid
Withdrawal Treatments Market Players include
Bayer AG,
F.
Hoffman-La Roche Ltd.,
Johnson
& Johnson Services,
Sanofi,
Novartis,
Pfizer
Inc.,
Teva
Pharmaceutical Industries Ltd., and
Merck
& Co.
Segmentation:
The
global Opioid Withdrawal Treatments Market Outlook has been segmented on the basis of drug
type, distribution channel, and region.
·
By drug type, the opioid withdrawal treatment market has been segmented
into nonsteroidal anti-inflammatory drugs, anti-nausea medications,
analgesics, natural sleep supplements, and others.
·
On the basis of distribution channel, the market has been segmented into hospital
pharmacy, retail pharmacies, and online stores.
Regional
Analysis:
The
Americas is likely to remain the leading regional Opioid Withdrawal Treatments
Market Outlook over the forecast period due to the growing demand for opioid
withdrawal treatments in the region. According to the CDC, two thirds of the
deaths attributed to drug overdoses in the U.S. in 2016 involved an opioid.
This is the major driver for the opioid withdrawal treatment market in North
America, as the increasing awareness about the involvement of opioids in drug
overdose cases is likely to be a major driver for the opioid withdrawal
treatment market over the forecast period. Increasing awareness about NSAIDs
and analgesics is likely to be a major driver for the Americas market for
opioid withdrawal treatment market in the Americas over the forecast period.
Increasing
development of other pain management medications in North America is also likely
to be a major driver for the opioid withdrawal treatment market in North
America over the forecast period. The major growth driver for the opioid
withdrawal treatment market has been the absence of other classes of pain
medications to deal with the pain problem without using opioids. Mankind’s
dependence on opioids has thus resulted in a growing demand for the development
of other pain medication classes, which can deliver comparable relief without
using opiates. North America is likely to be a major center for the development
of these drugs in the coming years, leading to a growing demand from the opioid
withdrawal treatment market over the forecast period.
Europe
accounts for the second largest market for opioid withdrawal treatments and is
likely to retain a considerable share in the global opioid withdrawal treatment
market over the forecast period.
About US:
Market
Research Future (MRFR) enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services.
Contact us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson
Street,5Th Floor, New York,
New York
10013
